Oxford BioDynamics Plc (LON:OBD – Get Free Report) traded down 22.9% during trading on Monday . The stock traded as low as GBX 0.76 ($0.01) and last traded at GBX 0.93 ($0.01). 1,731,795 shares changed hands during trading, a decline of 7% from the average session volume of 1,859,947 shares. The stock had previously closed at GBX 1.20 ($0.02).
Oxford BioDynamics Stock Up 9.6 %
The stock has a market cap of £3.21 million, a PE ratio of -16.30 and a beta of 0.42. The company has a debt-to-equity ratio of 370.22, a quick ratio of 2.80 and a current ratio of 0.68. The company’s 50-day moving average price is GBX 1.46 and its 200 day moving average price is GBX 4.69.
Insider Activity
In related news, insider David Holbrook acquired 49,653 shares of the business’s stock in a transaction that occurred on Monday, October 28th. The stock was bought at an average cost of GBX 1 ($0.01) per share, for a total transaction of £496.53 ($631.24). Insiders own 16.78% of the company’s stock.
About Oxford BioDynamics
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
See Also
- Five stocks we like better than Oxford BioDynamics
- What is a Stock Market Index and How Do You Use Them?
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Where Do I Find 52-Week Highs and Lows?
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
